Medicenna Therapeutics Corp faces a challenging trading day as its stock price drops significantly.
In the latest trading session, Medicenna Therapeutics Corp (MDNA.TO) saw its stock price decline by 3.80%, closing at CA$0.38. This downturn raises concerns among investors about the company's current market position and future prospects.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Medicenna Therapeutics Corp
MDNA.TO
MDNA.TO
Medicenna Therapeutics Corp
WealthAwesomeMarket cap
$33.69M
52W high
$1.97
52W low
$0.36
1W change
-6.41%
Beta
1.89
Analyst Price Targets
Based on analyst covering MDNA
Wall Street analysts forecast MDNA stock price to rise 776.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.20
+776.7% Upside
Current Price
C$0.36
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDNA's historical volatility
30-Day Vol
44.4%
Annualized
90-Day Vol
70.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.31
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.34 | C$0.30 – C$0.40 |
| 60 trading days | C$0.32 | C$0.26 – C$0.40 |
| 90 trading days | C$0.31 | C$0.23 – C$0.40 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should closely monitor Medicenna's performance and any upcoming news that could impact its stock, especially given the recent public offerings and market sentiment.
Medicenna's stock drops 3.80% in one day
With a market cap of CA$36.46 million, the stock's decline is significant for a company of this size, indicating potential volatility ahead.
Bull case
Despite today's drop, Medicenna has been actively securing funding through public offerings. This could provide the necessary capital for their ongoing projects and research, which may lead to future growth.
Bear case
The stock's decline today might reflect broader concerns about the company's financial health and whether its recent offerings will effectively boost long-term growth.
Market Reaction to Medicenna's Public Offerings
Medicenna has recently participated in several public offerings, including a notable one that raised about $4.44 million. While these efforts aim to strengthen the company's financial position, today's stock decline suggests that investor confidence may be shaky. The market often reacts cautiously to such offerings, especially if there are doubts about the company's long-term viability.
Potential Implications for Investors
The drop in Medicenna's stock price could signal a critical moment for investors. With a market cap under CA$40 million, any fluctuations can have a significant impact. Investors should evaluate their positions carefully, considering both the potential for recovery and the risks tied to the company's ongoing projects. Staying updated on further developments, such as clinical trial results or additional funding announcements, will be essential.
Advertisement
